Liều lượng khuyến cáo

Dosage varies depending on cancer type, treatment regimen, and individual patient factors. Refer to the prescribing information for complete dosing recommendations.

1. Ung thư đại trực tràng di căn (mCRC)

The recommended dosage when Alymsys is administered in combination with intravenous fluorouracil-based chemotherapy is:

• 5 mg/kg IV every 2 weeks with bolus-IFL chemotherapy
• 10 mg/kg IV every 2 weeks with FOLFOX4

After progression, patients may receive a dose of 5 mg/kg every 2 weeks or 7.5 mg/kg every 3 weeks.

2. Non-Small Cell Lung Cancer (NSCLC)

For patients with NSCLC, a dose of 15 mg/kg is given intravenously every 3 weeks in combination with carboplatin and paclitaxel.

3. U nguyên bào thần kinh đệm tái phát

For patients with recurrent glioblastoma, a dosage of 10 mg/kg is administered intravenously every 2 weeks.

4. Metastatic Renal Cell Carcinoma

The recommended dosage for patients with kidney cancer is 10 mg/kg, given intravenously every 2 weeks in combination with interferon alfa.

5. Persistent, Recurrent, or Metastatic Cervical Cancer

The recommended dosage is 15 mg/kg intravenously every 3 weeks in combination with paclitaxel and cisplatin or in combination with paclitaxel and topotecan.

6. Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

The recommended dosage is 10 mg/kg intravenously every 2 weeks in combination with paclitaxel, pegylated liposomal doxorubicin, or topotecan.